Northrop Grumman (NOC) Stock Forecast & Price Target

Northrop Grumman is supported by stronger-than-expected 3Q26 execution, with adjusted EPS about 10% above estimates, 7% sales growth to $11.1B, and adjusted FCF of $1.81B, even before considering the strength of its $109.6B backlog and 1.5x book-to-bill. The outlook is reinforced by 2027 guidance for 5%–7% sales growth, 10–20 bps of margin expansion, and $3.3B–$3.7B of FCF, with all four segments expected to grow and key programs such as B-21, Sentinel, and munitions backed by the budget. Management’s raised 2026 earnings outlook, improving segment margins, and optionality in microelectronics and foundry monetization further strengthen the case for durable operating leverage and multi-year growth.

Northrop Grumman is facing a weaker fundamental setup because the expected growth path appears largely priced in, while its best upside catalysts now depend on the B-21, space, and solid rocket motor programs that require incremental investment and carry execution risk. The loss of the F/A-XX program, coupled with cautious assumptions for FY27 and slower defense spending growth after FY27, limits top-line acceleration and reduces the chance of a meaningful valuation re-rating. FCF support also looks less compelling, with estimates around $3.5B to $3.6B in 2028 versus roughly $2.35B to $2.4B of capex, while margin expansion and capital return are constrained by program mix, budget uncertainty, and scrutiny over share repurchases.